Greater Than 10% Weight Loss Needed to Reduce Obesity-Linked Cancers
Observational data show bariatric surgery or GLP-1 agonists yield modest absolute risk reductions of 0.02% to 0.5% in cancer incidence.
The Clinical Lighthouse
Already a member?
or
The Clinical Lighthouse
Subscribe to read the full analysis
Full access to every article, clinical summary, and the daily evidence brief.
- Unlimited access to all articles
- Daily evidence digest
- Daily podcast with news summaries
- Lighthouse Guideline Briefings
- Ask Lumi: your guide to search, summarise, and explain the archive
- Cancel anytime